480 related articles for article (PubMed ID: 30321765)
21. [25S intron analysis followed by restriction enzyme digestion performed for genotyping Candida albicans isolates].
Karahan ZC; Saran B; Yenice S; Ağırbaşlı H; Arıkan Akan O; Tekeli A
Mikrobiyol Bul; 2012 Apr; 46(2):257-65. PubMed ID: 22639314
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
Sullivan DJ; Moran GP; Pinjon E; Al-Mosaid A; Stokes C; Vaughan C; Coleman DC
FEMS Yeast Res; 2004 Jan; 4(4-5):369-76. PubMed ID: 14734017
[TBL] [Abstract][Full Text] [Related]
23. Genotyping of Candida albicans on the basis of polymorphisms of ALT repeats in the repetitive sequence (RPS).
Iwata T; Hattori H; Chibana H; Mikami Y; Tomita Y; Kikuchi A; Kanbe T
J Dermatol Sci; 2006 Jan; 41(1):43-54. PubMed ID: 16364601
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients.
Millon L; Piarroux R; Drobacheff C; Monod M; Grenouillet F; Bulle B; Bole J; Blancard A; Meillet D
Med Mycol; 2002 Dec; 40(6):535-43. PubMed ID: 12521117
[TBL] [Abstract][Full Text] [Related]
26. Candida species distribution, genotyping and virulence factors of Candida albicans isolated from the oral cavity of kidney transplant recipients of two geographic regions of Brazil.
da Silva-Rocha WP; Lemos VL; Svidizisnki TI; Milan EP; Chaves GM
BMC Oral Health; 2014 Mar; 14():20. PubMed ID: 24628850
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals.
Mane A; Gaikwad S; Bembalkar S; Risbud A
J Med Microbiol; 2012 Feb; 61(Pt 2):285-290. PubMed ID: 21959206
[TBL] [Abstract][Full Text] [Related]
28. [An update on Candida dubliniensis].
Paugam A; Baixench MT; Viguié C
Med Mal Infect; 2008 Jan; 38(1):1-7. PubMed ID: 18065177
[TBL] [Abstract][Full Text] [Related]
29. Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis Malaysia.
Tay ST; Chai HC; Na SL; Ng KP
Mycopathologia; 2005 Apr; 159(3):325-9. PubMed ID: 15883714
[TBL] [Abstract][Full Text] [Related]
30. Candida dubliniensis does not show phospholipase activity: true or false?
Scheid LA; Mario DA; Lopes PG; Loreto Ed; Linares CE; Santurio JM; Alves SH
Rev Soc Bras Med Trop; 2010; 43(2):205-6. PubMed ID: 20464155
[TBL] [Abstract][Full Text] [Related]
31. 25S rDNA genotype and antifungal susceptibility of clinical Candida albicans in Ouagadougou (Burkina Faso).
Zida A; Issiaka S; Sanata B; Samuel SS; Ibrahim S; Marcel S; Thierry G; Kady TL; Robert GT
Med Mycol; 2018 Oct; 56(7):907-910. PubMed ID: 29228306
[TBL] [Abstract][Full Text] [Related]
32. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
Fotedar R; Al-Hedaithy SS
Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
[TBL] [Abstract][Full Text] [Related]
33. Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers.
Owotade FJ; Patel M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):455-60. PubMed ID: 25201119
[TBL] [Abstract][Full Text] [Related]
34. Detection of Candida dubliniensis in Venezuela.
Hartung de Capriles C; Mata-Essayag S; Pérez C; Colella MT; Roselló A; Olaizola C; Abate SM
Mycopathologia; 2005 Oct; 160(3):227-34. PubMed ID: 16205971
[TBL] [Abstract][Full Text] [Related]
35. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
[TBL] [Abstract][Full Text] [Related]
36. New PCR primer pairs specific for Candida dubliniensis and detection of the fungi from the Candida albicans clinical isolates in Japan.
Tamura M; Watanabe K; Imai T; Mikami Y; Nishimura K
Clin Lab; 2000; 46(1-2):33-40. PubMed ID: 10745979
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and genotypic detection of Candida albicans and Candida dubliniensis strains isolated from oral mucosa of AIDS pediatric patients.
Livério HO; Ruiz LDS; Freitas RS; Nishikaku A; Souza AC; Paula CR; Domaneschi C
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e14. PubMed ID: 28423089
[TBL] [Abstract][Full Text] [Related]
38. Genotypes analysis of Candida albicans species complex from healthy individual saliva in Ahvaz, Iran.
Kianifar S; Rezaei-Matehkolaei A; Zarei-Mahmoudabadi A
Lett Appl Microbiol; 2022 Oct; 75(4):831-835. PubMed ID: 35673982
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
[TBL] [Abstract][Full Text] [Related]
40. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei.
Koga-Ito CY; Komiyama EY; Martins CA; Vasconcellos TC; Jorge AO; Carvalho YR; do Prado RF; Balducci I
Mycoses; 2011 Sep; 54(5):e278-85. PubMed ID: 20492535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
